Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Omeros Corporation (OMER) Market Cap & Valuation Ratios

Omeros Corporation (OMER) has a market cap of $1.2B, with earnings according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

OMEROmeros CorporationFollow OMER — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
1.2B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
11 Nov, in 18 days

Peers

biotechnology · nearest by market cap · trailing 12 months
CompanyMkt cap, $BP/EEV/SalesEV/EBITDAFCF yieldRev. growthOp. marginROIC
OMER1.2———-5.7%——-365%
DMRA1.3———-0.5%———
TSHA1.3—161.2—-10.3%-32%——
NKTR1.3—10.7——-27%-258%-16%
LBRX1.2———-6.6%——-174%
RAPP1.2———-7.8%——-54%
TYRA1.2———-9.0%——-66%
SNDX1.2—3.5——+223%-77%—
AVLN1.2———————
BCAX1.1———-12.0%——-54%
VOR1.1———-13.0%———
Median of these 10—10.7—-9.0%-27%-167%-54%

.

Growth vs. price

each dot a company · hover or tap for values

Omeros Corporation — questions

What is Omeros Corporation's market cap?
$1.2B.

Every figure on this page comes from Omeros Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.